Biotech with Heart: Atara’s Path to Hope for MS & Cancer
Atara Biotherapeutics was named in honor of a patient—and that legacy still guides its work today. Dr. Kristin Yarema, former Chief Commercial Officer, shares how mission-driven biotech is changing the future of care.
Back to Seasons